A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)
Clinical trial NCT04848779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04848779
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-10
- Primary completion
- 2026-10-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.